FREDUN PHARMACEUTICALS L Share Price

₹ 1,447.50

+₹39.30 (2.79%)
1D
Last updated 03 Nov, 2026, 13:11 IST
NSE: FREDUN
|
Pharmaceuticals

FREDUN PHARMACEUTICALS L Share Price Today

As of 3 Nov 2026, FREDUN PHARMACEUTICALS L share price is ₹1,447.50. The stock opened at ₹1,432.00, compared to its previous close of ₹1,408.20. During today's trading session, FREDUN PHARMACEUTICALS L share price moved in the range of ₹1,413.10 to ₹1,460.00, with an average price of ₹1,436.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,195.20 and a high of ₹1,665.00. On the performance front, FREDUN PHARMACEUTICALS L share price has declined by 2.15% over the last six months and is down 2.15% on a year-on-year basis.

Share price over the last 1 day rose from 1441.90 to 1447.50, ranging between 1428.60 and 1460.00.
₹1,413.10
2.79% up today
₹1,460.00
1D LOW
1D HIGH

FREDUN PHARMACEUTICALS L Stock Insights

Latest Earning
Op Profit TrendUp by 82.67% QoQ
Latest Earning
Net Profit TrendUp by 21.80% QoQ
Latest Earning
Revenue TrendUp by 7.13% QoQ
Stock Performance
OutperformingBeat Nifty by 0.31 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 2.14%
Shareholding Pattern
DIIDII decreased stake by 54.66%
Shareholding Pattern
FIIFII decreased stake by 34.95%
FREDUN PHARMACEUTICALS L stock performance
Open₹1,432.00
High₹1,460.00
Low₹1,413.10
Prev. close₹1,408.20
FREDUN PHARMACEUTICALS L trading activity
Volume36,684
Average traded price₹1,443.50
Last traded time01:11:06 03 Nov
Last traded quantity1
Circuit
L
H
₹1,126.60
₹1,689.80
52-week
L
H
₹1,195.20
₹1,665.00
Mkt Cap Cr
2,412.72
P/E
55.05
P/B
7.04
ROA
6.82%
ROE
11.73%
ROCE
17.24%
Quick Ratio
0.77
EV/EBITDA
22.65

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Fredun Pharma outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Fredun Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Fredun Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

FREDUN PHARMACEUTICALS L Company Background

ISIN
INE194R01017
Sector Market Cap
₹ 2,412.72 Cr

Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, Nutraceuticals, Cosmeceuticals and Mobility. Its Generics Division, marketed under the Fredun Gx brand. The Pet Healthcare segment operates under the Freossi brand. The Nutraceutical Division under Fredun Nutrition brand. Its Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. Its Mobility Division, operating under Chuu Balm, BraceOn, NebOn, and DigiOn, caters to the ortho rehabilitation aids and pain management market. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It also provides comprehensive pet care technology platforms.

FREDUN PHARMACEUTICALS L Financial Highlights

  • Revenue: FREDUN PHARMACEUTICALS L reported revenue of ₹639.12 crore in FY26 vs ₹456.27 crore in FY25. It showed an increase of 40.07% on a yearly basis.
  • Operating Profit: FREDUN PHARMACEUTICALS L reported an operating profit of ₹47.00 crore in FY26 vs ₹27.49 crore in FY25. It showed an increase of 70.97% on a year-on-year basis.
  • Net Profit: FREDUN PHARMACEUTICALS L reported a net profit of ₹32.62 crore in FY26 vs ₹19.74 crore in FY25. It showed an increase of 65.25% on a yearly basis.

FREDUN PHARMACEUTICALS L Quarterly Result Highlights

  • FREDUN PHARMACEUTICALS L reported revenue of ₹228.25 crore in Jun 2026, compared with ₹213.06 crore in Mar 2026, representing an increase of 7.13% on a quarter-on-quarter (QoQ) basis.
  • FREDUN PHARMACEUTICALS L reported an operating profit of ₹20.55 crore in Jun 2026, compared with ₹11.25 crore in Mar 2026, representing an increase of 82.67% on a quarter-on-quarter (QoQ) basis.
  • FREDUN PHARMACEUTICALS L reported a profit of ₹13.13 crore in Jun 2026, compared with ₹10.78 crore in Mar 2026, reflecting an increase of 21.80% on a QoQ basis.
  • The earnings per share (EPS) of FREDUN PHARMACEUTICALS L stood at ₹66.81 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
43.62%
FII
0.69%
Other DII
1.33%
Retail and other
54.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20261.06%
Jun 20261.06%
Jul 20261.06%
Sep 20260.69%

FREDUN PHARMACEUTICALS L Investment Returns

1 day
+3.01%
1 week
+3.13%
1 month
+3.91%
1 year
-2.15%
3 years
-2.15%
5 years
-2.15%

FREDUN PHARMACEUTICALS L Share Price History

FREDUN PHARMACEUTICALS L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,360.00 / ₹1,408.20
+3.01%
30 Oct 26
₹1,455.00 / ₹1,367.00
-5.95%
29 Oct 26
₹1,476.00 / ₹1,453.50
-1.27%
28 Oct 26
₹1,471.00 / ₹1,472.20
+1.47%
Show more

FREDUN PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹635.47₹453.82
Other Income₹3.66₹2.45
Total Revenue₹639.12₹456.27
Total Expenses₹592.13₹428.78
Profit Before Tax₹47.00₹27.49
Tax₹14.38₹7.75
Profit After Tax₹32.62₹19.74
EPS - Basic₹66.81₹41.78
EPS - Diluted₹61.23₹42.53

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹32.62₹20.03
Income before WC changes₹80.84₹55.09
Change in Assets-₹28.56-₹169.59
Change in Liabilities-₹39.37₹97.91
Change in WC-₹67.93-₹71.68
Cash flow from Operations₹11.90-₹16.60
Cash flow from Investing-₹73.59-₹6.35
Cash flow from Financing₹121.45₹26.65
Total Cash Flow₹59.76₹3.70
Cash (Start of the year)₹5.22₹1.52
Cash (End of the year)₹64.98₹5.22

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹143.91₹60.21
Current Assets₹498.17₹427.20
Total Assets₹642.08₹487.41
Current Liabilities₹296.86₹328.10
Net Current Asset₹201.31₹99.11
Non-Current Liabilities₹67.11₹17.93
Equity Capital₹278.11₹141.38
Total Equity & Liabilities₹642.08₹487.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹635.47₹453.82₹348.16₹274.68
Other Income₹3.66₹2.45₹0.92₹1.82
Total Revenue₹639.12₹456.27₹349.07₹276.50
Total Expenses₹591.54₹428.00₹327.62₹258.99
Profit Before Tax₹47.58₹28.27₹21.45₹17.51
Tax₹14.38₹7.46₹5.83₹6.70
Profit After Tax₹33.21₹20.81₹15.62₹10.81
EPS - Basic₹68.01₹44.83₹33.81₹24.13
EPS - Diluted₹62.33₹44.37₹33.47₹22.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹33.21₹20.81₹15.62₹10.76
Income before WC changes₹81.10₹55.27₹38.22₹29.16
Change in Assets-₹25.15-₹174.13-₹54.39-₹62.33
Change in Liabilities-₹39.93₹96.41₹15.73₹18.76
Change in WC-₹65.08-₹77.72-₹38.66-₹43.57
Cash flow from Operations₹16.44-₹20.98-₹0.44-₹14.41
Cash flow from Investing-₹73.58-₹5.99-₹7.64-₹9.40
Cash flow from Financing₹121.82₹25.90₹5.99₹25.18
Total Cash Flow₹64.67-₹1.07-₹2.08₹1.36
Cash (Start of the year)₹0.28₹1.35₹3.44₹2.07
Cash (End of the year)₹64.95₹0.28₹1.35₹3.44

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹143.89₹64.40₹50.46₹41.07
Current Assets₹498.24₹422.25₹257.14₹216.21
Total Assets₹642.14₹486.65₹307.60₹257.28
Current Liabilities₹296.31₹327.32₹166.83₹139.66
Net Current Asset₹201.93₹94.93₹90.31₹76.55
Non-Current Liabilities₹67.11₹17.93₹19.30₹21.25
Equity Capital₹278.71₹141.40₹121.47₹96.38
Total Equity & Liabilities₹642.14₹486.65₹307.60₹257.28
* All values are in INR Crore
FREDUN PHARMACEUTICALS L market depth
Bid quantityBid priceAsk priceAsk quantity
21447.51448.92
11447.414498
314471449.31
51446.91449.81
51446.81449.95
Total bid quantity16
Total ask quantity17
FREDUN PHARMACEUTICALS L technical summary
Bearish indicators1
Neutral indicators4
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
42.76
Neutral
ATR (14)
77.73
Neutral
STOCH(9,6)
30.46
Neutral
STOCH RSI (14)
14.58
Bullish
ADX(9)
19.57
Bullish
UO(9)
51.34
Neutral
ROC(12)
-7.42
Bearish
WillR(14)
-80.55
Bullish
Period
Simple value
Exponential vaue
5D
1430.36
1412.52
10D
1408.1
1419.31
20D
1442.35
1418.88
50D
1421.86
1448.46
100D
1423.24
0
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

FREDUN PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

FREDUN PHARMACEUTICALS L Returns Calculator

Ex-date: 16 Jul 2026
Ex-date: 23 Jun 2026

Top Gainers

AEGISLOG Share Price
₹1240.10
+140 (+12.73%)
KRBL Share Price
₹398.00
+35 (+9.64%)
BALRAMCHIN Share Price
₹653.75
+53.85 (+8.98%)
MARICO Share Price
₹862.50
+63.95 (+8.01%)
CONCORDBIO Share Price
₹1239.40
+75.9 (+6.52%)
See more

Top Losers

KEC Share Price
₹313.85
-35.15 (-10.07%)
GNFC Share Price
₹471.70
-39.3 (-7.69%)
PRAJIND Share Price
₹258.50
-12.63 (-4.66%)
GESHIP Share Price
₹1532.40
-68 (-4.25%)
NATIONALUM Share Price
₹316.90
-11.1 (-3.38%)
See more

FREDUN PHARMACEUTICALS L Share Price FAQs

Please be aware that FREDUN PHARMACEUTICALS L stock prices are subject to continuous fluctuations due to various factors.